Dr. Fryer is interested in understanding the genetic basis for differentiation of neural stem cells to distinct phenotypes, including dopaminergic neurons known to succumb to degeneration in patients with Parkinson's disease. Once defining the role of genes important in driving differentiation, he is interested in modifying these cells via gene therapy type approaches to predispose the cells to become dopamine-producing neurons upon transplantation into Parkinson's Disease patients.